Big change in market-access strategies, execs say

What's the biggest change for today's pharma executive? Market access strategies, according to a survey by Cegedim Dendrite. Forty percent cited it as the part of their business undergoing the biggest changes, while 20 percent chose sales-force restructuring. Report